|1||NCT00006089||Completed||Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer||
||NIH / Other||
||34||Female||18 Years and older (Adult, Older Adult)||NCT00006089||NCI-2012-02356
|September 18, 2000||September 4, 2007||January 31, 2010||January 27, 2003||July 31, 2019||
|2||NCT02465060||Recruiting||Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)||
||6452||All||18 Years and older (Adult, Older Adult)||NCT02465060||NCI-2015-00054
|August 12, 2015||June 30, 2022||June 8, 2015||September 4, 2019||
† Study has passed its completion date and status has not been verified in more than two years.